Literature DB >> 26734577

Novel Imaging Diagnosis for Hepatocellular Carcinoma: Consensus from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014).

Bang-Bin Chen1, Takamichi Murakami2, Tiffany Ting-Fang Shih1, Michiie Sakamoto3, Osamu Matsui4, Byung-Ihn Choi5, Myeong-Jin Kim6, Jeong Min Lee7, Ren-Jie Yang8, Meng-Su Zeng9, Ran-Chou Chen10, Ja-Der Liang11.   

Abstract

Current novel imaging techniques in the diagnosis of hepatocellular carcinoma (HCC), with the latest evidence in this field, was discussed at the Asia-Pacific Primary Liver Cancer Expert (APPLE) meeting held in Taipei, Taiwan, in July 2014. Based on their expertise in a specific area of research, the novel imaging group comprised 12 participants from Japan, South Korea, Taiwan, and China and it included 10 abdominal radiologists, one hepatologist, and one pathologist. The expert participants discussed topics related to HCC imaging that were divided into four categories: (i) detection method, (ii) diagnostic method, (iii) evaluation method, and (iv) functional method. Consensus was reached on 10 statements; specific comments on each statement were provided to explain the rationale for the voting results and to suggest future research directions.

Entities:  

Keywords:  Consensus; Diagnostic imaging; Hepatocellular carcinoma

Year:  2015        PMID: 26734577      PMCID: PMC4698631          DOI: 10.1159/000367742

Source DB:  PubMed          Journal:  Liver Cancer        ISSN: 1664-5553            Impact factor:   11.740


  85 in total

1.  Recent advances in estimating hepatic functional reserve in patients with chronic liver damage.

Authors:  Satoru Imura; Mitsuo Shimada; Tohru Utsunomiya
Journal:  Hepatol Res       Date:  2014-04-24       Impact factor: 4.288

2.  Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients.

Authors:  Bang-Bin Chen; Chao-Yu Hsu; Chih-Wei Yu; Shwu-Yuan Wei; Jia-Horng Kao; Hsuan-Shu Lee; Tiffany Ting-Fang Shih
Journal:  Eur Radiol       Date:  2011-08-31       Impact factor: 5.315

3.  Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging--preliminary observations.

Authors:  Haruo Watanabe; Masayuki Kanematsu; Satoshi Goshima; Hiroshi Kondo; Minoru Onozuka; Noriyuki Moriyama; Kyongtae T Bae
Journal:  Radiology       Date:  2011-01-19       Impact factor: 11.105

Review 4.  Review of dynamic contrast-enhanced ultrasound guidance in ablation therapy for hepatocellular carcinoma.

Authors:  Yasunori Minami; Masatoshi Kudo
Journal:  World J Gastroenterol       Date:  2011-12-07       Impact factor: 5.742

5.  Hepatic necro-inflammation and elevated liver enzymes: evaluation with MRI perfusion imaging with gadoxetic acid in chronic hepatitis patients.

Authors:  B-B Chen; C-Y Hsu; C-W Yu; J-H Kao; H-S Lee; P-C Liang; S-Y Wei; R-M Hwang; T T-F Shih
Journal:  Clin Radiol       Date:  2014-02-18       Impact factor: 2.350

Review 6.  JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan.

Authors:  Masatoshi Kudo; Osamu Matsui; Namiki Izumi; Hiroko Iijima; Masumi Kadoya; Yasuharu Imai; Takuji Okusaka; Shiro Miyayama; Kaoru Tsuchiya; Kazuomi Ueshima; Atsushi Hiraoka; Masafumi Ikeda; Sadahisa Ogasawara; Tatsuya Yamashita; Tetsuya Minami; Koichiro Yamakado
Journal:  Liver Cancer       Date:  2014-10       Impact factor: 11.740

7.  Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.

Authors:  Alejandro Forner; Ramón Vilana; Carmen Ayuso; Lluís Bianchi; Manel Solé; Juan Ramón Ayuso; Loreto Boix; Margarita Sala; María Varela; Josep M Llovet; Concepció Brú; Jordi Bruix
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

8.  Use of contrast-enhanced ultrasonography with a perflubutane-based contrast agent performed one day after transarterial chemoembolization for the early assessment of residual viable hepatocellular carcinoma.

Authors:  Kenichi Takizawa; Kazushi Numata; Manabu Morimoto; Masaaki Kondo; Akito Nozaki; Satoshi Moriya; Tomohiro Ishii; Takashi Oshima; Hiroyuki Fukuda; Masahiro Okada; Shigeo Takebayashi; Shin Maeda; Katsuaki Tanaka
Journal:  Eur J Radiol       Date:  2013-06-13       Impact factor: 3.528

9.  Liver failure after major liver resection: risk assessment by using preoperative Gadoxetic acid-enhanced 3-T MR imaging.

Authors:  Andreas Wibmer; Alexander M Prusa; Richard Nolz; Thomas Gruenberger; Martin Schindl; Ahmed Ba-Ssalamah
Journal:  Radiology       Date:  2013-10-28       Impact factor: 11.105

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

View more
  5 in total

1.  MR visible localization device for radiographic-pathologic correlation of surgical specimens.

Authors:  Sonja Kinner; Tilman B Schubert; Elisabetta A Nocerino; Shannon Hynes; Timothy J Colgan; Agnes G Loeffler; Christopher Brace; Scott B Reeder; Emily Winslow
Journal:  Magn Reson Imaging       Date:  2016-11-27       Impact factor: 2.546

2.  Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition).

Authors:  Jian Zhou; Hui-Chuan Sun; Zheng Wang; Wen-Ming Cong; Jian-Hua Wang; Meng-Su Zeng; Jia-Mei Yang; Ping Bie; Lian-Xin Liu; Tian-Fu Wen; Guo-Hong Han; Mao-Qiang Wang; Rui-Bao Liu; Li-Gong Lu; Zheng-Gang Ren; Min-Shan Chen; Zhao-Chong Zeng; Ping Liang; Chang-Hong Liang; Min Chen; Fu-Hua Yan; Wen-Ping Wang; Yuan Ji; Wen-Wu Cheng; Chao-Liu Dai; Wei-Dong Jia; Ya-Ming Li; Ye-Xiong Li; Jun Liang; Tian-Shu Liu; Guo-Yue Lv; Yi-Lei Mao; Wei-Xin Ren; Hong-Cheng Shi; Wen-Tao Wang; Xiao-Ying Wang; Bao-Cai Xing; Jian-Ming Xu; Jian-Yong Yang; Ye-Fa Yang; Sheng-Long Ye; Zheng-Yu Yin; Bo-Heng Zhang; Shui-Jun Zhang; Wei-Ping Zhou; Ji-Ye Zhu; Rong Liu; Ying-Hong Shi; Yong-Sheng Xiao; Zhi Dai; Gao-Jun Teng; Jian-Qiang Cai; Wei-Lin Wang; Jia-Hong Dong; Qiang Li; Feng Shen; Shu-Kui Qin; Jia Fan
Journal:  Liver Cancer       Date:  2018-06-14       Impact factor: 11.740

3.  Vasculogenic mimicry in hepatocellular carcinoma contributes to portal vein invasion.

Authors:  Chen Jue; Wu Zhifeng; Zhang Zhisheng; Cui Lin; Qian Yayun; Jin Feng; Gu Hao; Ishikawa Shintaro; Tadashi Hisamitsu; Guo Shiyu; Liu Yanqing
Journal:  Oncotarget       Date:  2016-11-22

4.  Superselective Transarterial Chemoembolization for Unresectable or "Ablation Unsuitable" Hepatocellular Carcinoma in the Caudate Lobe: A Real World, Single-Center Retrospective Study.

Authors:  Liangliang Yan; Yanqiao Ren; Kun Qian; Xuefeng Kan; Hongsen Zhang; Lei Chen; Bin Liang; Chuansheng Zheng
Journal:  Front Oncol       Date:  2021-10-28       Impact factor: 6.244

5.  Consensus of Minimally Invasive and Multidisciplinary Comprehensive Treatment for Hepatocellular Carcinoma - 2020 Guangzhou Recommendations.

Authors:  Qi-Feng Chen; Wang Li; Simon Chun-Ho Yu; Yi-Hong Chou; Hyunchul Rhim; Xiaoming Yang; Lujun Shen; Annan Dong; Tao Huang; Jinhua Huang; Fujun Zhang; Weijun Fan; Ming Zhao; Yangkui Gu; Zhimei Huang; Mengxuan Zuo; Bo Zhai; Yueyong Xiao; Ming Kuang; Jiaping Li; Jianjun Han; Wei Song; Jie Ma; Peihong Wu
Journal:  Front Oncol       Date:  2021-07-02       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.